Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Gains from Sales and Divestitures (2022 - 2025)

Historic Gains from Sales and Divestitures for ASP Isotopes (ASPI) over the last 4 years, with Q3 2025 value amounting to $1.6 million.

  • ASP Isotopes' Gains from Sales and Divestitures fell 3749.87% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 3749.87%. This contributed to the annual value of $3.9 million for FY2024, which is 924.48% down from last year.
  • As of Q3 2025, ASP Isotopes' Gains from Sales and Divestitures stood at $1.6 million, which was down 3749.87% from $984330.0 recorded in Q2 2025.
  • ASP Isotopes' Gains from Sales and Divestitures' 5-year high stood at $4.3 million during Q4 2023, with a 5-year trough of $350000.0 in Q4 2022.
  • Moreover, its 4-year median value for Gains from Sales and Divestitures was $1.5 million (2023), whereas its average is $1.7 million.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first surged by 111930.4% in 2023, then crashed by 4719.79% in 2025.
  • Quarter analysis of 4 years shows ASP Isotopes' Gains from Sales and Divestitures stood at $350000.0 in 2022, then soared by 1119.3% to $4.3 million in 2023, then fell by 9.24% to $3.9 million in 2024, then plummeted by 59.6% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $984330.0 for Q2 2025, and $457115.0 during Q1 2025.